Serotonin antagonist and reuptake inhibitors (SARIs)
DBCAT005717Pharmacologic class
A class of drugs that are mainly used as antidepressants, but are also anxiolytics and hypnotics agents. A DrugBank category of 3 drugs. 3 of them are approved.
- Part of
- Serotonin Modulators
What you can answer from here — as of July 22, 2022
Which targets do Serotonin antagonist and reuptake inhibitors (SARIs) share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account